MARY J BLANTON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family JACKSON, TN NPI 1497784466
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TN Medtronic, Inc. All categories
General Payments — all program years on this page
$3,016.80
- Category: General Payments
- Program years: PY2021–2024
- Record count: 27
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $790.61 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $790.61 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $151.52 | 1 |
| Acerta Pharma LLC | $125.01 | 1 |
| GENZYME CORPORATION | $123.81 | 1 |
| Sumitomo Pharma America, Inc. | $119.55 | 1 |
| Novo Nordisk AS | $109.93 | 1 |
| Amgen Inc. | $104.45 | 1 |
| Axsome Therapeutics, Inc. | $56.34 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100556677 | Novo Nordisk Inc | $109.93 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105210142 | AstraZeneca Pharmaceuticals LP | $125.01 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116955452 | Medtronic, Inc. | $151.52 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117509108 | Amgen Inc. | $104.45 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139967963 | GENZYME CORPORATION | $123.81 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148389762 | Axsome Therapeutics, Inc. | $56.34 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148945437 | Sumitomo Pharma America, Inc. | $119.55 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.